Swaminathan P. Iyer

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-1646-813X

发表论文 529 篇 · 总被引 11458 次 · h-index 54

代表论文

• Clinical trial success rate in lymphoma: fate of trials and agents from 2000 to 2019 (2025 · Blood Advances · 被引 1)
• Trial in progress: Phase 2 trial of epcoritamab in combination with rituximab-mini CVP for older unfit/frail patients or anthracycline-ineligible adult patients with newly diagnosed diffuse large B-cell lymphoma (2025 · Blood · 被引 1)
• Immune effector cell-associated enterocolitis (IEC-EC) across CAR-T products in myeloma and lymphoma: A real world pharmacovigilance analysis (2025 · Blood · 被引 1)
• Interim analysis of safety and efficacy in a Phase 2 study of MB-105, a CD5.CAR T therapy for patients with relapsed/refractory T cell lymphoma (2025 · Blood · 被引 1)
• Impact of putative cell of origin on CD19+CAR-T outcomes in patients with large B-cell lymphoma (2025 · Blood · 被引 1)
• A novel CD94-targeting CAR T cell therapy for cytotoxic subtypes of T/NK-cell malignancies (2025 · Blood · 被引 1)